IHE News Alert DJ US Pharmaceuticals Ishares (IHE) 163.48 02/13/2015

New Post Public Reply Private Reply Replies (0) Message Board

Feb 14, 2015 at 12:17 AM

DJ US Pharmaceuticals Ishares (IHE) 163.48 $IHE

Pfizer Set to Acquire Hospira: Healthcare ETFs in Focus - ETF News And Commentary
Sweta Killa - Zacks Investment Research - Fri Feb 06, 9:00AM CST
Healthcare ETFs are worth a look given that Pfizer will buy Hospira.
IHE: 163.48 (+1.38), PPH: 67.69 (+0.60), IYH: 149.63 (+0.84), PFE: 34.64 (-0.23), HSP: 87.35 (unch), XLV: 70.72 (+0.28)

Big Pharma Weak Guidance Put These ETFs in Focus - ETF News And Commentary
Sweta Killa - Zacks Investment Research - Thu Feb 05, 10:00AM CST
How pharma ETFs are looking after the string of earnings beat and disappointing guidance?
IHE: 163.48 (+1.38), JNJ: 99.62 (+1.18), PPH: 67.69 (+0.60), PJP: 73.81 (+0.69), MRK: 58.81 (-0.07), PFE: 34.64 (-0.23), LLY: 70.56 (+0.03), BMY: 60.04 (+0.56)

Can Pharma ETFs Continue Their Uptrend In 2015?
Zacks Funds - Seeking Alpha - Fri Jan 09, 4:37PM CST
The pharmaceutical sector, which had been witnessing several tax inversion deals over the last few months, is not likely to go down this route given the Sep 2014 notice issued by the U.S. Department of the Treasury. New rules imposed by the Treasury...
IHE: 163.48 (+1.38), PPH: 67.69 (+0.60), PJP: 73.81 (+0.69), XPH: 118.58 (+0.98)

Can Pharma ETFs Continue their Uptrend in 2015? - ETF News And Commentary
Zacks Equity Research - ZACKS - Fri Jan 09, 11:00AM CST
Several factors suggest that Pharma ETFs may continue their strong performance this year as well.
IHE: 163.48 (+1.38), PPH: 67.69 (+0.60), PJP: 73.81 (+0.69), XPH: 118.58 (+0.98)

Where Do Cures Reside? The Answer Is In Regenerative Medicine
Life Sciences Report - Seeking Alpha - Fri Jan 09, 7:37AM CST
The practice of medicine is being transformed. The journey has been arduous, but revolutionary stem cell, gene and immunocellular therapies are rapidly moving toward pivotal milestones-and investors in the space should strap in for a rewarding joy...
BBP: 28.36 (+0.12), RXL: 131.80 (+1.10), XBI: 203.40 (+1.36), IHE: 163.48 (+1.38), IHF: 123.33 (-0.30), PPH: 67.69 (+0.60), XHE: 91.74 (+0.76), BBC: 28.98 (+0.18), PTH: 56.26 (+0.35), BBH: 122.45 (+0.86), FHLC: 34.19 (+0.16), IHI: 117.25 (+0.94), CURE: 135.77 (+1.84), FXH: 62.97 (+0.34), VHT: 130.56 (+0.66), RYH: 148.64 (+0.75), PBE: 52.78 (+0.30), IYH: 149.63 (+0.84), FBT: 110.21 (+1.02), XHS: 116.43 (-0.07), XPH: 118.58 (+0.98), XLV: 70.72 (+0.28), SBIO: 27.28 (+0.14), PSCH: 63.77 (+0.26), PJP: 73.81 (+0.69), RXD: 13.98 (-0.26)

Kyle Bass's Assault On Pharma Patents
IP Hawk - at Seeking Alpha - Thu Jan 08, 12:25PM CST

BBP: 28.36 (+0.12), RXL: 131.80 (+1.10), XBI: 203.40 (+1.36), IBB: 323.46 (+3.04), IHE: 163.48 (+1.38), IHF: 123.33 (-0.30), BBC: 28.98 (+0.18), PPH: 67.69 (+0.60), XHE: 91.74 (+0.76), PTH: 56.26 (+0.35), BBH: 122.45 (+0.86), FHLC: 34.19 (+0.16), IHI: 117.25 (+0.94), CURE: 135.77 (+1.84), FXH: 62.97 (+0.34), VHT: 130.56 (+0.66), RYH: 148.64 (+0.75), PBE: 52.78 (+0.30), IYH: 149.63 (+0.84), FBT: 110.21 (+1.02), XHS: 116.43 (-0.07), XPH: 118.58 (+0.98), XLV: 70.72 (+0.28), SBIO: 27.28 (+0.14), PSCH: 63.77 (+0.26), PJP: 73.81 (+0.69), RXD: 13.98 (-0.26)

Pharma ETFs In Focus On Allergan Takeover Deal
Zacks Funds - at Seeking Alpha - Sat Nov 22, 9:10PM CST
The health care space is witnessing 2014 as another banner year thanks to encouraging industry trends, solid corporate earnings and huge levels of merger and acquisition activities. The sector is clearly leading the broad market rally and this trend...
IHE: 163.48 (+1.38), AGN: 229.49 (+1.87), PPH: 67.69 (+0.60), ACT: 285.37 (+3.71), XPH: 118.58 (+0.98)

Pharma ETFs in Focus on Allergan Takeover Deal - ETF News And Commentary
Sweta Killa - ZACKS - Tue Nov 18, 12:00PM CST
Pharma ETFs could get further boost from Actavis and Allergan merger deal in the coming days.
IHE: 163.48 (+1.38), AGN: 229.49 (+1.87), VRX: 167.00 (-0.50), PPH: 67.69 (+0.60), ACT: 285.37 (+3.71), XPH: 118.58 (+0.98)

Big Pharma Solid Q3 Earnings Put These ETFs in Focus - ETF News And Commentary
Sweta Killa - ZACKS - Thu Oct 30, 1:00PM CDT
Pharma ETFs have been surging over the past one week buoyed by solid earnings from big industry players.
IHE: 163.48 (+1.38), JNJ: 99.62 (+1.18), PPH: 67.69 (+0.60), PJP: 73.81 (+0.69), MRK: 58.81 (-0.07), LLY: 70.56 (+0.03), BMY: 60.04 (+0.56)

Top 10 Momentum ETFs For October 27, 2014
CapitalCube - Seeking Alpha - Tue Oct 28, 12:11PM CDT
By Veibha Subramaniam The data was compiled using CapitalCube's ETF Screener Utilities and Health care were the biggest gainers Momentum ETFs have been identified as those ETFs that are trading at a price discount to their 52 week high...
IYH: 149.63 (+0.84), VDC: 127.48 (-0.41), RXL: 131.80 (+1.10), DTO: 81.31 (-5.12), UXI: 120.00 (+1.61), UPW: 97.56 (-2.59), XLU: 45.17 (-0.70), TQQQ: 106.86 (+2.63), SCO: 70.05 (-3.45), QLD: 145.98 (+2.45), IHE: 163.48 (+1.38), XLP: 49.50 (-0.23), FBG: 57.90 (+0.50), UGE: 100.04 (+0.53), IDU: 113.30 (-1.71), SPHD: 33.19 (-0.15), FHLC: 34.19 (+0.16), VPU: 98.07 (-1.43), RHS: 107.77 (-0.29), CURE: 135.77 (+1.84)

iShares Dow Jones U.S. Pharmaceuticals Index Fund (IHE)
Trading Central - Tue Oct 14, 11:22AM CDT
The iShares US Pharmaceuticals ETF (IHE) has reached our stop loss which was set at $133.10. Performance: -5.64%.
IHE: 163.48 (+1.38)

iShares Dow Jones U.S. Pharmaceuticals Index Fund (IHE) : Buy @ $141.05
Trading Central - Wed Sep 24, 9:01AM CDT
# TECHNICAL VIEW # (Daily Chart) *the iShares US Pharmaceuticals ETF has completed a healthy pull back on the 139.35 support (former top) *the ETF is supported by a rising trend line *as long as the process of higher tops and bottoms is intact...
IHE: 163.48 (+1.38)

iShares Dow Jones U.S. Pharmaceuticals Index Fund (IHE) : Take profit @ $137
Trading Central - Fri Sep 05, 8:55AM CDT
The iShares US Pharmaceuticals ETF (IHE) has struck against the 138.4 resistance and has broken below a rising trend line. Therefore, we CLOSE our LONG position on iShares US Pharmaceuticals ETF (IHE) @ 137. Perf: + 1.48%
IHE: 163.48 (+1.38)

IHE, BMY, LLY, PRGO: ETF Outflow Alert
ETFChannel.com - Mon Aug 25, 10:14AM CDT
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares US Pharmaceuticals ETF where we have detected an approximate $13.5 million dollar outflow -- that's a 1.9%...
IHE: 163.48 (+1.38)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Zika Virus: A Surprising Ally in Brain Cancer Fight

Here’s something you don’t hear every day: using a virus that typically targets the brain not as a foe, but as a formidable ally in the war against glioblastoma. It’s a gutsy play by UP Oncolytics, a scrappy biotech outfit cradled within Rosalind Franklin University’s Helix 51 incubator. Risky Bet on a Known Adversary Glioblastoma—a real beast in the cancer...

Food Trends Tease: 2027 sofi™ Awards' 75 Finalists

The Specialty Food Scene Heats Up Today’s world doesn’t rest when it comes to innovation, and the same goes for the tantalizing realm of specialty foods. Hot off the press, the Specialty Food Association (SFA) just rolled out the red carpet for its 75 finalists in the 2027 sofi™ Awards. These are the future taste shapers set to take center stage at the Winter...

Steel Dynamics' Q3 2026: Record Shipments Boost Profits

Steel Dynamics Shatters Records in Q3 2026 If there was any doubt about Steel Dynamics' ability to ride the waves in the steel and aluminum market, the third quarter of 2026 put that to rest. With a record-breaking 3.8 million tons of steel shipped and net sales reaching a steep $6.5 billion, this isn't just business as usual—it's smashing their own ceiling. Operating...

Understanding Truck Accident Settlements in Memphis

Delving into Truck Accident Settlement Timelines Out there in Memphis, timing a truck accident settlement isn't exactly like clockwork work. When it comes to getting your compensation, the timeline varies as widely as a duck hunting trip—sometimes you come home with a basketful, sometimes it’s empty. It might be a quick couple of months or drag on past a year, and...

AAI Rolls Out Agency Gauge: AI-Driven Insights Platform

Bringing Artificial Intelligence to the Insurance Table Affordable American Insurance (AAI) is shaking things up in the insurance world with their new tool, Agency Gauge. Picture this: you're running an independent agency, neck-deep in data, and this AI-powered marvel swoops in and turns those confusing numbers into actionable business insights. It's like having a wise...

Cruise Planners Sets AI Benchmark in Travel Innovs

Unveiling the AI Arsenal of Cruise Planners Alright, listen up, folks. When you think about travel and tech, Cruise Planners ain't just dipping a toe—they're cannonballing right in, splashing everyone around with their shiny new AI tricks. Twenty-three. That's how many innovations they're flaunting this year. It's like they're running a tech marathon, and boy, are they...

OppFi Readies Q3 Earnings; Investors Eye Financials

What's Unfolding at OppFi? Mark your calendars, folks. October 28th is the day OppFi (NYSE: OPFI) pulls the curtain back on its third-quarter 2026 earnings. For the uninitiated, we're talking about a tech-driven finance platform that's been making waves by providing financial solutions for everyday Americans. And you bet we're all ears for what those numbers say. Details...

Cancer Memoir Shows Healing Beyond Medicine

Confronting the Unfathomable Out of the North Carolina mountains comes a story that defies expectations—a pastor and farmer named Mark Heisey, who faced the no-holds-barred trials of stage IV-B lymphoma. Now, I'll shoot you straight: this isn't your run-of-the-mill self-help guide or a clinical breakdown of battling cancer. His new memoir dives into the personal and...

Ruth E. Carter Returns Home with Celebrated Exhibition

Ruth E. Carter’s Triumphant Return When a titan of the costume design world circles back to their roots, you know it’s bound to be something special. Ruth E. Carter, who has swapped needles and threads for Oscars (twice, mind you), is making a return to Hampton University, paying homage to the very soil that sowed her artistic seeds. Ain't that a capstone of a career...

Art Print Paper: Finding the Perfect Match for Masterpieces

You ever stand in a gallery and notice how some art just lights up the room while others barely get a second glance? Well, a lot of that magic starts with an unsung hero—paper choice. I came across this bit from HelloNation diving into what makes paper selection a cornerstone for fine art prints. Now, I ain't an artist, but even a bruiser trader like me can see the...